Logo for Mirati Therapeutics Inc

Mirati Therapeutics Investor Relations Material

Latest events

Logo for Mirati Therapeutics Inc

Q2 2023

Mirati Therapeutics
Logo for Mirati Therapeutics

Q3 2023

6 Nov, 2023
Logo for Mirati Therapeutics

Q2 2023

8 Aug, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Mirati Therapeutics Inc

Access all reports
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer. The company's portfolio consists of several product candidates meant to treat for example various hematologic cancers, including leukemia. The company cooperates with other medical companies to develop their products.